Related Experiment Video
Updated: May 5, 2026

10:17
Improving Student Outcomes with an Adaptable Molecular Cloning Course-Based Undergraduate Research Experience
Published on: November 15, 2024
1.8K
Developing a clinical research associate training program at Dillard University: the impact of collaboration
Charlotte Hurst1, Betty P Dennis
1School of Nursing, Dillard University, New Orleans, LA, USA. churst@dillard.edu
Summary
A new research center aims to boost minority participation in clinical trials by training more minority clinical research associates (CRAs) in Louisiana. This initiative addresses health disparities and promotes diversity in medical research.
Area of Science:
- Health Disparities Research
- Clinical Trials
- Minority Health
Background:
- Dillard University and Louisiana State University Health Sciences Center established a Minority Health and Health Disparities Research Center (MHHDRC) in 2010.
- The MHHDRC is the first federally funded Center of Excellence in Louisiana, focusing on reducing health disparities.
- A key component of the MHHDRC is a clinical research associate (CRA) training program.
Purpose of the Study:
- To increase the number of minority CRAs in Louisiana, particularly in New Orleans.
- To enhance minority participation and retention in clinical trials research.
- To detail the establishment, operation, and impact of the CRA training program within the MHHDRC.
Main Methods:
- Collaboration between Dillard University and Louisiana State University Health Sciences Center.
- Securing a five-year grant from the National Institute of Minority Health and Health Disparities.
- Development and implementation of a clinical research associate (CRA) training program.
- Community outreach and integration of multiple resources.
Main Results:
- Successful establishment of the first federally funded Center of Excellence for Minority Health and Health Disparities in Louisiana.
- Initiation of a CRA training program designed to increase minority representation in clinical research.
- Facilitation of greater minority participation and retention in clinical trials.
Conclusions:
- The collaborative effort successfully launched a vital research center and training program.
- The CRA training program is crucial for addressing minority underrepresentation in clinical trials.
- Future plans aim to sustain and expand the impact of the MHHDRC and its initiatives.
More Related Videos
Related Concept Videos
Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K

